Shareholders' Equity and Share-based Compensation (Tables)

9 Months Ended

Mar. 31, 2026

Share-Based Payment Arrangement, Noncash Expense [Abstract]

Restricted Stock Units Activity

Time-based Restricted Stock Units (“TRSUs”)

The following table summarizes the Company’s TRSU activities for the nine months ended March 31, 2026:

	Number of Time-based Restricted Stock Units	Weighted Average Grant Date Fair Value Per Share		Weighted Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value
Nonvested at June 30, 2025	1,491,926	$	28.50	1.66	$	38,282,821
Granted	756,381	$	22.42
Vested	(533,089)	$	30.63
Forfeited	(94,803)	$	29.27
Nonvested at March 31, 2026	1,620,415	$	24.91	1.85	$	35,908,396

The following table summarizes the Company’s MSUs activities for the nine months ended March 31, 2026:

	Number of Market-based Restricted Stock Units	Weighted Average Grant Date Fair Value Per Share		Weighted Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value
Nonvested at June 30, 2025	1,436,000	$	32.32	2.89	$	36,847,760
Vested	(267,500)	$	5.17
Forfeited	(74,000)	$	48.44
Nonvested at March 31, 2026	1,094,500	$	37.86	2.64	$	24,254,120

The following table summarizes the Company’s PRSUs activities for the nine months ended March 31, 2026:

	Number of Performance-based Restricted Stock Units	Weighted Average Grant Date Fair Value Per Share		Weighted Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value
Nonvested at June 30, 2025	409,563	$	27.71	1.85	$	10,509,387
Granted	204,000	$	21.43
Vested	(138,808)	$	30.75
Forfeited	(11,817)	$	46.07
Nonvested at March 31, 2026	462,938	$	23.56	2.07	$	10,258,706

Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions

The assumptions used to estimate the fair values of common shares issued under the ESPP were as follows:

	Nine Months Ended March 31,
	2026
Volatility rate	76.0%
Risk-free interest rate	3.7%
Expected term	1.3 years
Dividend yield	—%

Share-based Compensation, Allocation of Recognized Period Costs

Share-based Compensation Expense

The total share-based compensation expense recognized in the Condensed Consolidated Statements of Loss for the periods presented was as follows:

	Three Months Ended March 31,				Nine Months Ended March 31,
	2026		2025		2026		2025
	(in thousands)				(in thousands)
Cost of goods sold	$	1,071	$	1,047	$	3,368	$	3,185
Research and development	1,231		1,890		5,378		6,018
Selling, general and administrative	2,799		4,199		11,760		12,785
	$	5,101	$	7,136	$	20,506	$	21,988